(Q28268808)

https://api.crossref.org/works/10.1517/14712598.5.9.1147

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.5.9.1147

Microtubule-interfering activity of parthenolide

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.5.9.1147

Suppressed NF-kB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-a induced apoptosis in human cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.5.9.1147

Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.5.9.1147

Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.5.9.1147

Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear's foot

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.5.9.1147

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Preferential induction of apoptosis for primary human leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Camptothecin and taxol: historic achievements in natural products research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Plants as source of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Ethnobotany and its role in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Dual role of the anti-inflammatory sesquiterpene lactone: regulation of life and death by parthenolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147

Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.9.1147